Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results

[1]  N. Yadav,et al.  Intravitreal Bevacizumab (Avastin) for Choroidal Neovascularization Secondary to Pathologic Myopia , 2009 .

[2]  T. Lai,et al.  Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. , 2007, Ophthalmology.

[3]  L. Aiello,et al.  SHORT–TERM EFFECTS OF INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA , 2007, Retina.

[4]  H. Rehm,et al.  A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort , 2007, Genetics in Medicine.

[5]  P. Venkatesh,et al.  Intravitreal Bevacizumab (Avastin) as Primary Treatment for Myopic Choroidal Neovascularization , 2007, European journal of ophthalmology.

[6]  Christine M. Cheng,et al.  Bevacizumab for Neovascular Ocular Diseases , 2007, The Annals of pharmacotherapy.

[7]  J. Montero,et al.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study , 2007, British Journal of Ophthalmology.

[8]  R. Apte,et al.  Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia. , 2006, Retina.

[9]  J. Slakter,et al.  Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab. , 2006, Retina.

[10]  T. Lai,et al.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study , 2006, British Journal of Ophthalmology.

[11]  Philip J Rosenfeld,et al.  Ranibizumab: Phase III clinical trial results. , 2006, Ophthalmology clinics of North America.

[12]  Y. Tano,et al.  Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia , 2006, British Journal of Ophthalmology.

[13]  M. Sánchez-Salorio,et al.  Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization. , 2006, American journal of ophthalmology.

[14]  J. Duker,et al.  Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia , 2006, British Journal of Ophthalmology.

[15]  K. Choy,et al.  Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. , 2006, American journal of ophthalmology.

[16]  J. Jonas,et al.  Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization. , 2005, Acta ophthalmologica Scandinavica.

[17]  M. Mochizuki,et al.  Myopic choroidal neovascularization: a 10-year follow-up. , 2003, Ophthalmology.

[18]  J. Ruiz-Moreno,et al.  Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes , 2003, The British journal of ophthalmology.

[19]  H. Heimann,et al.  Concentric retinal pigment epithelium atrophy after a single photodynamic therapy , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  J. Ruiz-Moreno,et al.  Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation , 2003, The British journal of ophthalmology.

[21]  R. Jm,et al.  Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes. , 2002 .

[22]  Y. Tano,et al.  Foveal translocation surgery and myopic subfoveal CNV membrane. , 2000, Ophthalmology.

[23]  A. Uemura,et al.  [Subretinal surgery for choroidal neovascularization]. , 2000, Nippon Ganka Gakkai zasshi.

[24]  Matthew A. Thomas,et al.  Subretinal surgery for choroidal neovascularization in patients with high myopia. , 2000, Archives of ophthalmology.

[25]  G Coscas,et al.  Long-Term Visual Outcome of Choroidal Neovascularization in Pathologic Myopia: Natural History and Laser Treatment , 1997, European journal of ophthalmology.

[26]  G. Soubrane,et al.  Etiology of choroidal neovascularization in young patients. , 1996, Ophthalmology.

[27]  P. Venkatesh,et al.  Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization. , 2007, European journal of ophthalmology.

[28]  H. Dua,et al.  Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia , 2005 .

[29]  J. Ruiz-Moreno,et al.  Long-Term Visual Acuity after Argon Green Laser Photocoagulation of Juxtafoveal Choroidal Neovascularization in Highly Myopic Eyes , 2002, European journal of ophthalmology.

[30]  George A. Williams,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. , 2001, Ophthalmology.